About Guillaume
French
Native or bilingual
English
Fluent
Experience
- INPHINE, SASTransformation and AI Consultant, Founding PresidentCONSULTING AND AUDITSJanuary 2022 - Today (4 years and 5 months)Paris, FranceCompany dedicated to supporting businesses in identifying, scoping, deploying, and adopting artificial intelligence solutions and transformation tools.• Definition of AI and data needs. Prioritization of use cases and definition of the roadmap based on business challenges, maturity, and transformation objectives.• Conducting benchmarks and comparative analyses of AI solutions based on their relevance, integrability, and expected ROI.• Monitoring emerging uses and immersion in the AI innovation ecosystem (Numeum, Station F events, international events, technological partnerships, …).• Supporting tool integration and their adoption by teams.• Intervention in transforming environments. Structuring change management and communication around the initiated transformations.Clients: Derma Leather (luxury tannery in Portugal), Évian (Danone Group), Real estate transaction company, INNIT (nutritional scoring algorithm), Nestlé Waters, SAFAC (plastic injection company), medium-sized city in the Paris metropolitan area.Assisting management in combining strategy, innovation, AI, and transformation. Ability to analyze, plan, benchmark solutions, mobilize partners, and support adoption decisions.
- Direction de la Médecine des Forces, Service de Santé des ArméesPrincipal Officer (Commander), operational reserveDEFENSE AND MILITARYJanuary 2023 - Today (3 years and 5 months)Tours, France• Leadership and coordination, management of officers and non-commissioned officers.• Contribution within a structured institutional framework, mission-oriented and with a high level of demand.• Mobilization of qualities of rigor, reliability, discernment, and team spirit.• Transverse valorization of data for operational purposes.
- Projet HEMERAInitiator and Project LeadBIOTECHJanuary 2012 - January 2016 (4 years)Paris, FranceDevelop and market an algorithm to predict the efficacy or inefficacy of anti-epileptic treatments.• Address the therapeutic wandering of epileptic patients. Annual cost in France of approximately €3 billion for inappropriate anti-epileptic treatment.• Target market of 40,000 new cases per year in France (600,000 in Europe).• Consider treatment success as a whole: efficacy, side effects, adherence, and costs.• The most comprehensive multidisciplinary approach possible (genetics, medical, drug interactions, personal environment, …).• Formation and management of an international scientific committee (neurology, pharmaco-epidemiology, pharmacogenetics, predictive statistics, market access,).• 'Pilot' study (80 patients), confirming the impact of genetic and other factors on the success of anti-epileptic treatment.• Market study (1376 patients) based on the health insurance reimbursement database, confirming the target market.• Business plan writing.Move away from siloed thinking and consider the patient in all their characteristics. Activate the necessary skills for project success. Mobilize all stakeholders.
Recommendations
Be the first to recommend Guillaume
Help this freelancer shine by sharing your experience working together.
These freelancer profiles also match your criteria
Agatha Frydrych
Backend Java Software Engineer
4.7
(3)
2
Baptiste Duhen
Fullstack developer
4.6
(4)
5
Amed Hamou
Senior Lead Developer
4
(2)
7
Audrey Champion
Web developer
4.3
(3)
4
Education
- AI for BusinessÉcole Polytechnique2025AI for Business, certification
- Master 2 Management and Business AdministrationIAE de Caen2011Master 2 Management et Administration des Entreprises
Certifications
- AI for BusinessEcole Polytechnique2025